Pfizer reported positive results for its experimental eczema drug tilrekimig after it met the main goal in a Phase 2 trial for moderate-to-severe atopic dermatitis. The company now plans to move the treatment into late-stage Phase 3 testing.
Dr Reddy’s Laboratories receives USFDA EIR for Srikakulam facility after GMP and PAI inspection, strengthening regulatory compliance and global pharma manufacturing credibility.
Gland Pharma receives USFDA tentative approval for Brimonidine Tartrate Ophthalmic Solution, 0.025%, expanding its ophthalmic portfolio and strengthening its US market presence.
U.S. drugmaker Eli Lilly will continue selling its innovator diabetes and obesity drug at premium prices in India even as the market prepares for the arrival of lower-priced generic drugs. The company says it is not planning price reduction...
.jpeg)
Emcure partners with Roche to improve access to life-saving nephrology and transplant treatments in India. The collaboration expands care for CKD, anemia, and organ transplants.
Eli Lilly's tirzepatide holds premium pricing in India ahead of March 2026 generics rush. With explosive sales and stronger efficacy than competitors, the company sees room for both branded and low-cost options.
Eli Lilly and Company (India) has launched the next phase of its obesity awareness campaign, using films led by well-known personalities to shift the focus from blame to science and encourage doctor-led care.
Novo Nordisk has signed a $2.1 billion deal with Vivtex to develop an oral obesity drug platform, aiming to turn injectable weight-loss treatments into easy-to-take pills and expand patient access worldwide.
Shilpa Medicare has signed a strategic licensing agreement with SteinCares to commercialize a biosimilar across Latin America, strengthening its biologics portfolio and expanding its presence in emerging markets.
Lupin has secured European Commission approval for its biosimilar ranibizumab, marking a major step in expanding access to advanced eye care treatments across the European Union.
, CDSCO.jpg)